Transparency Reporting
For transparency purposes and pursuant to applicable law, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Belgium on www.betransparent.be, including the name, amount and nature of the transfer of value and any other required information. Transfers of value granted in the framework of scientific research are disclosed on www.betransparent.be on an aggregated basis.
Inquiries about the disclosed transfers of value should be directed to [email protected].
LuxembourgFor transparency purposes and in accordance with the applicable laws and/or ethics rules, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Luxembourg on the appropriate platform, including the name, amount and nature of the transfer of value and any other required information.
The disclosure reports for Luxembourg may be consulted below:
Gilead Sciences Luxembourg EFPIA Report 2020 (in English)
Gilead Sciences Luxembourg EFPIA Report 2020 (in French)
Gilead Sciences Luxembourg EFPIA Methodological Note 2020
Gilead Sciences Luxembourg EFPIA Report 2019 (in English)
Gilead Sciences Luxembourg EFPIA Report 2019 (in French)
Gilead Sciences Luxembourg EFPIA Methodological Note 2019
Gilead Sciences Luxembourg EFPIA Report 2018 (in English)
Gilead Sciences Luxembourg EFPIA Report 2018 (in French)
Gilead Sciences Luxembourg EFPIA Methodological Note 2018
Inquiries about the disclosed transfers of value should be directed to [email protected].